Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report – PR Newswire (press release)
|
Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report
PR Newswire (press release) Interestingly, Ocata Therapeutics (previously ACT) is conducting similar research, but the company has moved away from its initial focus on iPSCs and has instead chosen to focus on human embryonic stem cells (hESCs). It is currently conducting clinical … |
